Read
- IRS official refuses to answer questions at scandal hearing
|
- Global stocks, oil fall after Bernanke; dollar gains
|
- Oklahoma tornado victims astounded at how they survived
|
- CORRECTED-White House threatens veto of bill to bypass Obama on Keystone
- FBI says man shot dead while being questioned about Boston bombings
Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
Message of humility
A religious fraternity in Rio considers the election of Pope Francis, a confirmation of their beliefs in poverty and simplicity. Slideshow
Sponsored Links
Takeda to stop selling 13 Pfizer drugs in Japan
The logo of Japanese Takeda Pharmaceutical Co is seen at an office building in Glattbrugg near Zurich March 7, 2012.
Credit: Reuters/Arnd Wiegmann
TOKYO |
TOKYO (Reuters) - Takeda Pharmaceutical Co, Japan's biggest drugmaker, said on Monday it will stop distributing 13 Pfizer Inc drugs it now sells in Japan at the end of this year and Pfizer itself will begin selling them from 2013.
The 13 drugs include antibiotic Minomycin, anticancer agents Torisel and Mylotarg, and depression treatment Amoxan. The list did not include Viagra.
Takeda said it will continue to distribute Prevenar, a pneumococcus vaccine for children, and the haemophilia B drug BeneFIX. It also said it and Pfizer will continue to work together on the arthritis drug Enbrel.
(Reporting by Mayumi Negishi; Editing by Michael Watson)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters